These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1445599)

  • 41. Lack of activities of amikacin and sulphamethoxazole against Mycobacterium avium-intracellulare.
    Yew WW; Tam CM; Chan CY; Li MS; Cheng AF
    Int J Clin Pharmacol Res; 1993; 13(2):65-8. PubMed ID: 8354590
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Postantibiotic effects and postantibiotic effects of subinhibitory levels of quinolines on Pseudomonas aeruginosa].
    Hostacká A
    Epidemiol Mikrobiol Imunol; 1996 May; 45(2):56-8. PubMed ID: 8756401
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gepotidacin (GSK2140944)
    Flamm RK; Farrell DJ; Rhomberg PR; Scangarella-Oman NE; Sader HS
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28483959
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bactericidal activity in vitro of various rifamycins against Mycobacterium avium and Mycobacterium tuberculosis.
    Heifets LB; Lindholm-Levy PJ; Flory MA
    Am Rev Respir Dis; 1990 Mar; 141(3):626-30. PubMed ID: 2155555
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [A supplement study on the in vitro activity of sulfadimethoxine on Mycobacterium avium complex--combined effect with other antituberculosis drugs].
    Tsukamura M
    Kekkaku; 1989 Jun; 64(6):379-86. PubMed ID: 2507819
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mycobacterium tuberculosis Is Selectively Killed by Rifampin and Rifapentine in Hypoxia at Neutral pH.
    Iacobino A; Piccaro G; Giannoni F; Mustazzolu A; Fattorini L
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993848
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activity in vitro of rifabutin, FCE 22807, rifapentine, and rifampin against Mycobacterium microti and M. tuberculosis and their penetration into mouse peritoneal macrophages.
    Dhillon J; Mitchison DA
    Am Rev Respir Dis; 1992 Jan; 145(1):212-4. PubMed ID: 1309967
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Postantibiotic effect of ampicillin/sulbactam against mycobacteria.
    Prabhakaran K; Harris EB; Randhawa B
    Microbios; 1999; 99(393):113-22. PubMed ID: 10510868
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro activity of aminoglycosides, clofazimine, d-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates.
    Huang CC; Wu MF; Chen HC; Huang WC
    J Microbiol Immunol Infect; 2018 Oct; 51(5):636-643. PubMed ID: 28705770
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment.
    van Ingen J; Egelund EF; Levin A; Totten SE; Boeree MJ; Mouton JW; Aarnoutse RE; Heifets LB; Peloquin CA; Daley CL
    Am J Respir Crit Care Med; 2012 Sep; 186(6):559-65. PubMed ID: 22744719
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparing the Genotype and Drug Susceptibilities between Mycobacterium avium and Mycobacterium intracellulare in China.
    Zheng HW; Pang Y; He GX; Song YY; Zhao YL
    Biomed Environ Sci; 2017 Jul; 30(7):517-525. PubMed ID: 28756811
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TLC G-65 in combination with other agents in the therapy of Mycobacterium avium infection in beige mice.
    Cynamon MH; Klemens SP; Swenson CE
    J Antimicrob Chemother; 1992 Jun; 29(6):693-9. PubMed ID: 1387133
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The postantibiotic effect of amikacin alone and in combination with piperacillin on gram-negative bacteria.
    Isaksson B; Hanberger H; Maller R; Nilsson LE; Nilsson M
    Scand J Infect Dis Suppl; 1990; 74():129-32. PubMed ID: 2129064
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High efficacy of clofazimine and its synergistic effect with amikacin against rapidly growing mycobacteria.
    Shen GH; Wu BD; Hu ST; Lin CF; Wu KM; Chen JH
    Int J Antimicrob Agents; 2010 Apr; 35(4):400-4. PubMed ID: 20138481
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Postantibiotic effect of imipenem, alone and in combination with amikacin, on Pseudomonas aeruginosa.
    Gerçeker AA; Otük G
    Chemotherapy; 1995; 41(6):433-6. PubMed ID: 8529433
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effect of superinhibitory levels of imipenem and amikacin singly or in combination on Pseudomonas aeruginosa].
    Hostacká A
    Epidemiol Mikrobiol Imunol; 1997 Dec; 46(4):155-7. PubMed ID: 9471306
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhancement of antibiotic susceptibility and suppression of Mycobacterium avium complex growth by poloxamer 331.
    Hunter RL; Jagannath C; Tinkley A; Behling CA; Nolte F
    Antimicrob Agents Chemother; 1995 Feb; 39(2):435-9. PubMed ID: 7726511
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to various drugs].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1991 Jul; 66(7):489-92. PubMed ID: 1890791
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative in vitro activities of rifamycin analogues against Mycobacterium leprae.
    Dhople AM
    Indian J Lepr; 1997; 69(4):377-84. PubMed ID: 9474513
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outer membrane proteins and elastase of Pseudomonas aeruginosa after the postantibiotic effect induced by amikacin.
    Hostacká A; Karelová E
    Chemotherapy; 1997; 43(2):118-22. PubMed ID: 9084920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.